Black Cohosh Extract.
Research-backed herb with potential health benefits. It's the standardised root extract studied for temperature comfort through the midlife hormonal shift, and for the easier evening settling that tends to go with it.
Reviewed March 2026
- Category
- Herb
What Black Cohosh Extract is, and what it does.
- Does it work
- Suits women through the midlife hormonal shift who want a non-oestrogenic option. Anyone taking it wants a label naming the species and the triterpene glycoside content.
- How much to take
- Start with 20 to 40mg of standardised extract a day, which is where this root earns its keep. The 80mg seen in studies is a research condition, not a daily target.
- Time to feel it
- Four to eight weeks at 20 to 40mg a day. Changes in temperature comfort build gradually rather than arriving on a set morning.
- The first dose
- Day one is quiet. A little stomach heaviness if you take it on an empty stomach, and the effects it is studied for accumulate over weeks.
- With regular use
- Across four to eight weeks of daily use, temperature comfort measures shift gradually, and settling more easily in the evening is what people describe alongside that.
- How well tolerated
- Usually well tolerated, and mild stomach upset is the common complaint. Rare liver-related case reports exist, so talk to your doctor first if you take other medicines.
- How it feels
- Nothing stimulating and nothing sedating from the capsule itself. What people describe is fewer waves of heat through the day and evenings that settle more easily.
- The overlooked benefit
- It is not an isoflavone herb. Modern analysis of authenticated root finds no meaningful formononetin, so the old plant-oestrogen story does not describe what this actually is.
20 to 40mg a day is where Black Cohosh Extract works.
Source: Leach & Moore 2012 Cochrane Review. Standardized to 2.5% triterpene glycosides.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Black Cohosh Extract is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
- Temperature comfort through the midlife hormonal shiftMeta-analysis
- Sleep quality during the midlife hormonal shiftRandomised trial
- Mood steadiness in midlife womenRandomised trial
- Serotonin receptor activity as the proposed routeIn vitro study
- Absence of oestrogen receptor binding by standardised extractIn vitro study
Questions people ask about Black Cohosh Extract.
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Chaste tree acts on dopaminergic control of prolactin at the pituitary, an upstream endocrine point, while black cohosh acts on serotonergic receptor signalling linked with temperature regulation. Midlife formulas combine the two for their different levels of action.
Sage has a long record of use for sweating and thermal comfort through anticholinergic activity at sweat glands, a peripheral site. Black cohosh acts centrally on serotonergic temperature signalling.
Red clover supplies isoflavones with weak estrogen receptor beta affinity, whereas black cohosh does not bind estrogen receptors and instead acts on serotonergic pathways. Combining them covers midlife comfort from two independent mechanisms.
St John's Wort induces CYP3A4 and P-glycoprotein, which changes the handling of many co-taken compounds. Black cohosh constituents are metabolised hepatically, so the two are formulated together with that in mind. The pairing is conventional; the interaction direction is pharmacology rather than a combination trial.
A 2022 systematic review catalogued plant extracts with human HPA axis marker data and names both. Cortisol and related readouts are markers, not outcomes, and the review did not test the two together. The shared axis is what makes the pairing coherent on paper.
Rhodiola is studied for fatigue and stress-marker endpoints and shares the HPA axis framing that black cohosh formulas often use. The two are not co-studied in the candidate set. The connection is mechanistic overlap plus formulation convention.
Flaxseed lignans are converted by gut bacteria to enterolignans, a different route from anything black cohosh contributes. The pairing widens the phytochemical profile of a formula. It is convention, not a co-studied combination.
Calcium is the mineral substrate for normal bone maintenance and its handling is textbook. Black cohosh sits in the same formula for a different reason. Note that calcium at gram doses competes with iron and zinc for absorption, which matters when the same capsule carries them.
Magnesium is a cofactor for hundreds of enzymatic reactions and participates in normal bone mineral structure. It is added to black cohosh formulas for those independent roles. There is no described chemical interaction between the two.
A 2025 systematic review of randomised trials examined curcumin in postmenopausal women and names black cohosh in its background. The review covers curcumin, not the combination. Read the pairing as two separately studied botanicals placed in one formula.
Silymarin is studied for hepatocellular markers and is often placed alongside concentrated botanical extracts. Black cohosh is metabolised hepatically, which is the reason the pairing shows up. Marker data is not outcome data and no combination trial exists in the candidate set.
High-dose concentrated catechin extracts carry their own hepatic monitoring guidance from several regulatory bodies. Stacking two concentrated extracts raises the total botanical load a person is taking at once. The point is dose stacking rather than a described chemical interaction.
Vitamin K2 is the cofactor for gamma-carboxylation of osteocalcin, the step that lets that protein bind calcium in bone matrix. That is settled biochemistry and independent of black cohosh. The three-way calcium, D and K2 grouping is why K2 keeps company with black cohosh in women's formulas.
Nothing specific on file for Black Cohosh Extract. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Black Cohosh Extract actually does.
The underground stem and root carry a family of triterpene glycosides, mostly actein and 27-deoxyactein, plus cinnamic acid esters and phenolic acids. Extracts get standardised on triterpene glycoside content because that fraction is what defines the material.
Those triterpene glycosides don't dissolve well in water, so black cohosh is made as an alcohol or isopropanol extract rather than a water infusion. The solvent you pick changes which constituents end up concentrated in the finished powder.
Actaea racemosa gets adulterated often with related Asian Actaea species, which carry a different triterpene profile. That's exactly why DNA barcoding and HPLC fingerprinting of the triterpene pattern are the standard identity checks here.
In most lab studies of receptor binding, standardised black cohosh extracts show little meaningful binding at oestrogen receptors alpha and beta. So a direct oestrogenic mechanism is not the current explanation for its effects.
Where Black Cohosh Extract comes from.
It comes from the underground stem of a North American woodland plant. The root is dug up, dried, ground and soaked in an alcohol and water mixture, because plain water does not pull out the active compounds. The liquid is then concentrated, tested and dried into a powder. A big part of the work is confirming the plant is the right species, since look-alike plants from Asia get substituted.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Wild-harvested or cultivated black cohosh from eastern North American woodland, dug in autumn once the aerial parts die back. Wild collection pressure is why cultivated and forest-farmed supply has grown.
Roots are washed free of soil, dried to a low moisture content and milled. Identity is checked against related Actaea species by macroscopic inspection, HPLC fingerprint or DNA barcode before the material moves on.
The milled root is percolated or macerated in ethanol and water, or in aqueous isopropanol, since the triterpene glycosides do not come out in plain water.
The extract is filtered and the solvent is removed under vacuum at reduced temperature, leaving a concentrated soft extract. Residual solvent is measured against pharmacopoeial limits.
The concentrate is assayed by HPLC and adjusted with a carrier such as maltodextrin or microcrystalline cellulose so each batch declares the same glycoside percentage, commonly 2.5 percent expressed as 27-deoxyactein.
The standardised concentrate is spray-dried or vacuum-dried to a free-flowing powder, screened for particle size, and blended into capsules or tablets. Liquid lines stop at the fluid extract stage instead.
The forms it comes in.
The essence, in one line each.
- Pooling randomised trials in older women, black cohosh showed no detectable difference from placebo in hot flush frequency, and the authors judged the evidence insufficient to draw a firm conclusion.Meta-analysis. Leach et al., 2012 (The Cochrane database of systematic reviews). PMID 22972105 ↗
- In healthy adults, 28 days of black cohosh did not measurably change the activity of the CYP1A2, 2D6, 2E1 or 3A4 drug-processing enzymes, while other herbs in the same study did.Randomised trial. Gurley et al., 2005 (Clinical pharmacology and therapeutics). PMID 15900287 ↗
- The review catalogued plants and phytonutrients with human data on hypothalamic-pituitary-adrenal axis markers and names black cohosh among them; the endpoints are markers, not clinical outcomes.Systematic review. Lopresti et al., 2022 (Nutritional Neuroscience). PMID 33650944 ↗
- A randomised trial of kudzu flower and mandarin peel reported changes in hot flush scoring and bone turnover markers; black cohosh appears only as background context, not as a tested arm.Randomised trial. Kim et al., 2020 (Nutrients). PMID 33105861 ↗
- A systematic review of randomised trials of curcumin on postmenopausal symptoms; black cohosh is named in the review's framing of botanical options rather than evaluated.Systematic review. Akyakar et al., 2025 (International Journal of Molecular Sciences). PMID 40943181 ↗
- Soy protein containing isoflavones and isoflavone extracts were reviewed for plasma lipid changes in postmenopausal women; lipid values are markers rather than outcomes, and black cohosh is named only in context.Systematic review. Barańska et al., 2021 (Nutrients). PMID 34444691 ↗
- A standardised Eurycoma longifolia water extract was tested for well-being scores in perimenopausal and postmenopausal women; black cohosh is referenced as a comparator botanical in the background, not tested.Randomised trial. Muniandy et al., 2023 (BMJ Open). PMID 37914304 ↗
- A randomised, double-blind, placebo-controlled crossover trial of resveratrol supplementation in postmenopausal women; black cohosh appears only as a named botanical in the discussion of alternatives.Randomised trial. Dzator et al., 2022 (Nutrients). PMID 35565731 ↗
- A combination of botanical actives was tested for skin parameters and antioxidant status in postmenopausal women; black cohosh is named among botanicals used in this population rather than being an arm of the trial.Randomised trial. Tumsutti et al., 2022 (Journal of Cosmetic Dermatology). PMID 34260808 ↗
These are the studies our verdict leans on, chosen from the 174 we read for Black Cohosh Extract. The full linked list is below.
The studies, linked.
2 sources behind our Black Cohosh Extract verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialPhase 3 Study - Efficacy and Tolerance for the Mixture of Dry Extracts Black Cohosh and Saint John's Worth Versus Isolated Black Cohosh Extract for the Climacteric Symptoms' ControlClinicalTrials.gov ↗PHASE3 · 210 participants · Unknown
- Clinical trialBlack Cohosh Extract for the Treatment of Moderate to Severe Menopausal Symptoms: a Randomized-placebo Controlled TrialClinicalTrials.gov ↗PHASE3 · 60 participants · Unknown
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 209 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Black Cohosh Extract is, not how risky it is. A report is not proof Black Cohosh Extract caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
